Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 May 1;179(5):1713-7.
doi: 10.1084/jem.179.5.1713.

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus

Affiliations

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus

S Jonjić et al. J Exp Med. .

Abstract

Virus shedding from the epithelial cells of the serous acini of salivary glands is a major source for the horizontal transmission of cytomegalovirus. These cells are, different to other tissues, exempt from CD8 T lymphocyte control. CD4 T lymphocytes are essential to terminate the productive infection. Here, we prove that T-B cooperation and the production of antibodies are not required for this process. For the infection with murine cytomegalovirus, mutant mice were used which do not produce antibodies because of a disrupted membrane exon of the immunoglobulin mu chain gene. Also, in these mice the virus clearance from salivary glands is a function of CD4 T lymphocytes. However, these mice clear the virus and establish viral latency with a kinetics that is distinguishable from normal mice. Reactivation from virus latency is the only stage at which the absence of antibodies alters the phenotype of infection. In immunoglobulin-deficient mice, virus recurrence results in higher virus titers. The adoptive serum transfer proved that antibody is the limited factor that prevents virus dissemination in the immunodeficient host.

PubMed Disclaimer

References

    1. Nature. 1984 Dec 6-12;312(5994):548-51 - PubMed
    1. J Infect Dis. 1981 Feb;143(2):231-7 - PubMed
    1. J Immunol. 1986 Dec 15;137(12):3742-7 - PubMed
    1. J Exp Med. 1987 Mar 1;165(3):650-6 - PubMed
    1. J Virol. 1987 Oct;61(10):3102-8 - PubMed

Publication types

Substances